Systemic Mastocytosis Latest Advances

Treatment of systemic mastocytosis with associated hematologic neoplasm: midostaurin and beyond.

Journal: Expert review of hematology

Published: April 07, 2026

CD25+ mast cell hyperplasia in myeloid/lymphoid neoplasm with PDGFRA rearrangement mimicking systemic mastocytosis.

Journal: Blood

Published: February 26, 2026

Multiphasic anaphylaxis in the emergency and intensive care setting.

Journal: BMJ case reports

Published: February 26, 2026

Midostaurin-Cladribine Therapy for Neonatal Aggressive Systemic Mastocytosis.

Journal: Pediatric blood & cancer

Published: February 18, 2026

CRISPR/Cas9 engineered and whole-genome characterized KIT D816V-mutant human iPSC lines.

Journal: Stem cell research

Published: February 13, 2026

Aggressive systemic mastocytosis complicated with acute myeloid leukemia harboring the RUNX1::RUNX1T1 fusion gene: a case report

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: February 09, 2026

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Journal: European journal of dermatology : EJD

Published: January 29, 2026

Mast Cell Activation Syndrome: Quantification of Mast Cells Across Conditions Reveals Limited Diagnostic Utility of Mast Cell Counts and Tryptase Depletion Index.

Journal: Archives of pathology & laboratory medicine

Published: January 27, 2026

Honeybee venom immunotherapy: An Australian Centre experience over 15 years.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: January 22, 2026

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

Journal: Cells

Published: January 15, 2026

Refractory cutaneous symptoms in systemic mastocytosis.

Journal: JAAD case reports

Published: January 15, 2026

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.

Journal: Leukemia & lymphoma

Published: January 10, 2026

Systemic Mastocytosis Latest Advances

Find the Latest Research About Systemic Mastocytosis

Treatment of systemic mastocytosis with associated hematologic neoplasm: midostaurin and beyond.

Treatment of systemic mastocytosis with associated hematologic neoplasm: midostaurin and beyond.

CD25+ mast cell hyperplasia in myeloid/lymphoid neoplasm with PDGFRA rearrangement mimicking systemic mastocytosis.

CD25+ mast cell hyperplasia in myeloid/lymphoid neoplasm with PDGFRA rearrangement mimicking systemic mastocytosis.

Multiphasic anaphylaxis in the emergency and intensive care setting.

Multiphasic anaphylaxis in the emergency and intensive care setting.

Midostaurin-Cladribine Therapy for Neonatal Aggressive Systemic Mastocytosis.

Midostaurin-Cladribine Therapy for Neonatal Aggressive Systemic Mastocytosis.

CRISPR/Cas9 engineered and whole-genome characterized KIT D816V-mutant human iPSC lines.

CRISPR/Cas9 engineered and whole-genome characterized KIT D816V-mutant human iPSC lines.

Aggressive systemic mastocytosis complicated with acute myeloid leukemia harboring the RUNX1::RUNX1T1 fusion gene: a case report

Aggressive systemic mastocytosis complicated with acute myeloid leukemia harboring the RUNX1::RUNX1T1 fusion gene: a case report

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Mast Cell Activation Syndrome: Quantification of Mast Cells Across Conditions Reveals Limited Diagnostic Utility of Mast Cell Counts and Tryptase Depletion Index.

Mast Cell Activation Syndrome: Quantification of Mast Cells Across Conditions Reveals Limited Diagnostic Utility of Mast Cell Counts and Tryptase Depletion Index.

Honeybee venom immunotherapy: An Australian Centre experience over 15 years.

Honeybee venom immunotherapy: An Australian Centre experience over 15 years.

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

Refractory cutaneous symptoms in systemic mastocytosis.

Refractory cutaneous symptoms in systemic mastocytosis.

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.